Maternal-fetal medicine (Wolters Kluwer Health, Inc.)最新文献

筛选
英文 中文
Is a Fetus a Living Entity? Reframing the Question of Its Right to Survive in Contemporary Maternal-Fetal Medicine. 胎儿是生命体吗?当代母胎医学对其生存权问题的重构。
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-05-08 DOI: 10.1097/FM9.0000000000000352
Pragnesh Parmar, Gunvanti Rathod
{"title":"Is a Fetus a Living Entity? Reframing the Question of Its Right to Survive in Contemporary Maternal-Fetal Medicine.","authors":"Pragnesh Parmar, Gunvanti Rathod","doi":"10.1097/FM9.0000000000000352","DOIUrl":"10.1097/FM9.0000000000000352","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"432-434"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706329/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Antenatally Diagnosed Isolated or Nonisolated Nonvisualization of the Fetal Gallbladder in a Chinese Population: A Single-Center Cohort Study. 在中国人群中,产前诊断为分离性或非分离性未显像的胎儿胆囊的结局:一项单中心队列研究。
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-06-15 DOI: 10.1097/FM9.0000000000000365
Shuangping Liu, Ping An, Ying Zhao, Shudao Wu, Wentao Jin, Yunyun Ren, Yu Xiong
{"title":"Outcomes of Antenatally Diagnosed Isolated or Nonisolated Nonvisualization of the Fetal Gallbladder in a Chinese Population: A Single-Center Cohort Study.","authors":"Shuangping Liu, Ping An, Ying Zhao, Shudao Wu, Wentao Jin, Yunyun Ren, Yu Xiong","doi":"10.1097/FM9.0000000000000365","DOIUrl":"10.1097/FM9.0000000000000365","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the fetal prognosis of prenatally ultrasound-detected nonvisualization of the fetal gallbladder (NVFGB) in Chinese populations for prenatal counseling practice.</p><p><strong>Methods: </strong>This retrospective cohort study examined pregnant women whose fetuses received an antenatal diagnosis of isolated or nonisolated NVFGB at the Fetal Medicine Multi-Disciplinary Consultation Center, Obstetrics and Gynecology Hospital of Fudan University, between January 1, 2010, and February 10, 2023. NVFGB was defined as the inability to identify the fetal gallbladder during two targeted ultrasound examinations conducted within one week. Cases were classified as nonisolated if the ultrasound revealed additional sonographic abnormalities. The primary outcome measure compared the rates of favorable and poor prognoses, where a poor prognosis included biliary atresia, medically indicated termination of pregnancy, or neonatal death. Additionally, the adjunctive clinical utility of prenatal magnetic resonance imaging (MRI) was assessed in specific cases of NVFGB.</p><p><strong>Results: </strong>Fifty-five cases of NVFGB, comprising 27 isolated and 28 nonisolated instances, were included in this study. No marked differences were identified in baseline characteristics, such as maternal age, history of abnormal pregnancy, Down's screening results, or gestational age at the time of diagnosis. When compared with the nonisolated group, isolated NVFGB was associated with a more favorable prognosis (100.0% <i>vs.</i> 64.3%; <i>P</i> = 0.002; risk ratio (<i>RR</i>): 1.50, 95% confidence interval (<i>CI</i>): 1.149-1.959) and a significantly lower incidence of the composite adverse outcome (biliary atresia, medical indication termination of pregnancy, or neonatal death) (0 <i>vs.</i> 32.1%; <i>P</i> = 0.002; <i>RR</i>: 0, 95% <i>CI</i>: 0-0.837). The incidence of biliary atresia was 0 in the isolated group and 10.7% in the nonisolated group. Among the six cases that underwent MRI screening, the gallbladder was visualized normally in three instances (50%).</p><p><strong>Conclusion: </strong>The results of this retrospective cohort study suggest that isolated NVFGB is associated with a favorable prognosis, whereas nonisolated NVFGB is linked to an elevated risk of poor outcomes, such as biliary atresia or neonatal death. In certain cases where NVFGB is prenatally diagnosed, antepartum MRI may serve as an effective adjunct to detailed structural ultrasound.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"345-351"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion Management in Pregnancies Complicated by Hemoglobinopathies: Evidence, Guidelines, and Clinical Challenges. 妊娠合并血红蛋白病的输血管理:证据、指南和临床挑战。
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-05-11 DOI: 10.1097/FM9.0000000000000353
Sophia Delicou, Aikaterini Xydaki, Maria Moraki, Aikaterini Poulaki, George Daskalakis
{"title":"Transfusion Management in Pregnancies Complicated by Hemoglobinopathies: Evidence, Guidelines, and Clinical Challenges.","authors":"Sophia Delicou, Aikaterini Xydaki, Maria Moraki, Aikaterini Poulaki, George Daskalakis","doi":"10.1097/FM9.0000000000000353","DOIUrl":"10.1097/FM9.0000000000000353","url":null,"abstract":"<p><p>This review examined the evidence and guidelines on transfusion strategies, targets, and complications in pregnant women with hemoglobinopathies through a narrative review of literature published from 2010 to 2025, including randomized trials, observational studies, systematic reviews, and guidance from the American Society of Hematology, the British Society for Haematology (BSH), and International Society of Blood Transfusion, as well as regional recommendations and consensus statements from thalassemia-endemic areas such as China and Southeast Asia. The findings show that pregnancy substantially alters transfusion requirements and risks in this population. In sickle cell disease, prophylactic transfusion strategies targeting hemoglobin levels of 10-11 g/dL and sickle hemoglobin fractions below 30% are associated with reduced vaso-occlusive complications and improved maternal and fetal outcomes (Grade B evidence, supported by BSH, the Society for Maternal-Fetal Medicine, and observational meta-analyses). In β-thalassemia major, transfusion support during pregnancy typically requires intensification to maintain hemoglobin levels between 9.5-10.5 g/dL (Grade B, BSH guideline), particularly because interruption of iron chelation therapy during gestation increases the risk of iron overload and cardiac complications. Chinese and Southeast Asian expert recommendations similarly support maintaining hemoglobin at or above 10 g/dL to promote fetal growth and reduce maternal cardiac stress (Grade C, expert consensus). At the same time, transfusion-related complications, including alloimmunization, delayed hemolytic reactions, circulatory overload, acute lung injury, and iron toxicity, remain important clinical concerns. Overall, transfusion management in pregnancies complicated by hemoglobinopathies requires individualized, evidence-based strategies, careful surveillance for complications, and close multidisciplinary collaboration to optimize maternal and fetal outcomes, while incorporation of global and regional evidence enhances the relevance and applicability of current recommendations.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"406-416"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global, Regional, and National Burden of Neural Tube Defects and Digestive Congenital Anomalies in Newborns, 1990-2021, With Projections to 2050: Results From the 2021 Global Burden of Disease Study. 新生儿神经管缺陷和消化道先天性异常的全球、地区和国家负担,1990-2021年,预测到2050年:来自2021年全球疾病负担研究的结果
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-09-03 DOI: 10.1097/FM9.0000000000000377
Hong Zeng, Hao Chen, Qiao He, Danqing Zhao
{"title":"Global, Regional, and National Burden of Neural Tube Defects and Digestive Congenital Anomalies in Newborns, 1990-2021, With Projections to 2050: Results From the 2021 Global Burden of Disease Study.","authors":"Hong Zeng, Hao Chen, Qiao He, Danqing Zhao","doi":"10.1097/FM9.0000000000000377","DOIUrl":"10.1097/FM9.0000000000000377","url":null,"abstract":"<p><strong>Objective: </strong>To provide global, regional, and national estimates of disability-adjusted life years (DALYs) for neural tube defects (NTDs) and digestive congenital anomalies (DCAs) from 1990 to 2021, with projections to 2050, to inform resource allocation and identify high-burden populations.</p><p><strong>Methods: </strong>Using data from the Global Burden of Disease 2021 study, we analyzed the burden of NTDs and DCAs through descriptive and trend analyses. Age-standardized rates were examined by sex, age, region, and socio-demographic index (SDI). Temporal trends from 1990 to 2021 were assessed using estimated annual percentage change (EAPC). Future trends were forecast using exponential smoothing and ARIMA models.</p><p><strong>Results: </strong>Between 1990 and 2021, the global burden of NTDs and DCAs declined. The age-standardized incidence rate (ASIR) of NTDs decreased from 2.94 to 1.95, while the ASIR of DCAs fell from 8.09 to 7.42. DALYs for both conditions also declined. Females consistently had higher ASIRs and age-standardized DALY rates than males, with the largest burden in children under 5 years. Low SDI regions experienced the highest burden, while high-middle SDI regions saw the fastest decline. Projections indicate a continued decrease in the burden of NTDs and DCAs through 2050.</p><p><strong>Conclusion: </strong>Although the global burden of NTDs and DCAs has decreased over the past three decades, substantial disparities persist, particularly among women and populations in low-SDI regions. These findings highlight the need for targeted public health initiatives, optimized allocation of healthcare resources, and strengthened monitoring and intervention measures to reduce disparities in the disease burden of birth defects.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"358-370"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Residual Multiple-Pregnancy Risk After Elective Single Embryo Transfer: Why Intracytoplasmic Sperm Injection-Associated Monozygotic Twinning Still Matters. 选择性单胚胎移植后的剩余多胎妊娠风险:为什么卵浆内单精子注射相关的同卵双胞胎仍然很重要。
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-07-14 DOI: 10.1097/FM9.0000000000000371
Keliang Wu
{"title":"The Residual Multiple-Pregnancy Risk After Elective Single Embryo Transfer: Why Intracytoplasmic Sperm Injection-Associated Monozygotic Twinning Still Matters.","authors":"Keliang Wu","doi":"10.1097/FM9.0000000000000371","DOIUrl":"10.1097/FM9.0000000000000371","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"325-326"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intracytoplasmic Sperm Injection-Associated Increased Risk of Monozygotic Twins Following Elective Single Embryo Transfer: A Retrospective Cohort Analysis. 选择性单胚胎移植后单卵双胞浆内精子注射相关风险增加:回顾性队列分析。
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-06-18 DOI: 10.1097/FM9.0000000000000367
Liduan Zhou, Jing Chen, Xiyang Wang, Qingchen Cui, Lili Pan, Youzhu Li
{"title":"Intracytoplasmic Sperm Injection-Associated Increased Risk of Monozygotic Twins Following Elective Single Embryo Transfer: A Retrospective Cohort Analysis.","authors":"Liduan Zhou, Jing Chen, Xiyang Wang, Qingchen Cui, Lili Pan, Youzhu Li","doi":"10.1097/FM9.0000000000000367","DOIUrl":"10.1097/FM9.0000000000000367","url":null,"abstract":"<p><strong>Objective: </strong>To explore the primary factors influencing monozygotic twinning (MZT) in patients undergoing assisted reproductive technology (ART) at a single center to clarify the mechanisms of MZT formation.</p><p><strong>Methods: </strong>This retrospective cohort study analyzed 2952 elective single embryo transfer (eSET) cycles conducted between December 2014 and December 2023 at the First Affiliated Hospital of Xiamen University, which resulted in 1363 clinical pregnancies. The examined variables included parental age, fertilization method, cycle type (fresh <i>vs</i>. frozen-thawed), and embryo stage (cleavage <i>vs</i>. blastocyst). Clinical pregnancy was diagnosed through human chorionic gonadotropin (hCG) levels 12-14 days post-transfer and confirmed via transvaginal ultrasound at 6-7 weeks of gestation. MZT was defined by the presence of additional gestational sacs (dichorionic) or two embryos within a single sac (monochorionic), while a monozygotic singleton (MZS) was defined as one embryo per sac.</p><p><strong>Results: </strong>The overall MZT incidence was 0.85% (25/2952) per cycle and 1.83% (25/1363) per pregnancy (1 morula, 4 cleavage-stage, and 20 blastocyst transfers). After excluding the morula case, 24 MZT pregnancies were matched 1:4 with singletons. After matching, embryo stage and cycle type (16 fresh and 8 frozen-thawed MZT cases) demonstrated no significant effect on MZT rates. When the analysis was restricted to blastocyst transfer (20 MZTs and 80 singletons), neither parental age nor cycle type showed a significant correlation with MZT occurrence, whereas the fertilization method was significantly associated with MZT frequency. Regarding embryo morphology, all 20 MZT blastocysts featured high-quality (grade A or B) inner cell masses and trophectoderms, with no grade C embryos observed. Multivariate logistic regression confirmed that the use of intracytoplasmic sperm injection (ICSI) significantly increased the risk of MZT, whereas parental age and cycle type did not.</p><p><strong>Conclusion: </strong>The fertilization method affects MZT incidence, with the ICSI procedure and sperm quality serving as key correlates. Furthermore, high-quality blastocysts may possess a higher potential for MZT, providing new insights for the development of individualized embryo transfer strategies.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"327-333"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706257/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric Analysis of Fetal Membrane Research: Trends, Networks, and Future Directions (1998-2025). 胎儿膜研究的文献计量学分析:趋势、网络和未来方向(1998-2025)。
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-05-29 DOI: 10.1097/FM9.0000000000000364
Yongmei Shen, Hefei Wang, Maolin Nie, Jiasong Cao, Yaqi Li, Rongxin Wei, Junli He, Qimei Lin, Ying Chang
{"title":"Bibliometric Analysis of Fetal Membrane Research: Trends, Networks, and Future Directions (1998-2025).","authors":"Yongmei Shen, Hefei Wang, Maolin Nie, Jiasong Cao, Yaqi Li, Rongxin Wei, Junli He, Qimei Lin, Ying Chang","doi":"10.1097/FM9.0000000000000364","DOIUrl":"10.1097/FM9.0000000000000364","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"435-438"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706509/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Plasma Short-Chain Fatty Acids and Hypertensive Disorders of Pregnancy: A Nested Case-Control Study. 血浆短链脂肪酸与妊娠期高血压疾病的关系:一项巢式病例-对照研究
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-08-26 DOI: 10.1097/FM9.0000000000000375
Dandan Wang, Lei Wu, Pei Feng, Yexiu Sun, Di Wu, He Xu, Hao Peng, Hongmei Li
{"title":"Association between Plasma Short-Chain Fatty Acids and Hypertensive Disorders of Pregnancy: A Nested Case-Control Study.","authors":"Dandan Wang, Lei Wu, Pei Feng, Yexiu Sun, Di Wu, He Xu, Hao Peng, Hongmei Li","doi":"10.1097/FM9.0000000000000375","DOIUrl":"10.1097/FM9.0000000000000375","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the associations between plasma short-chain fatty acids (SCFAs) and hypertensive disorders of pregnancy (HDP).</p><p><strong>Methods: </strong>A nested case-control study was conducted comprising 387 pairs of HDP cases and non-HDP controls. The HDP group included 291 cases of gestational hypertension (GH) and 96 of preeclampsia (PE) or chronic hypertension (CH) with superimposed PE (PE/CH-PE). Seven plasma SCFA levels were assayed at gestational weeks 16-20, before HDP onset. The individual effects of the seven SCFAs on HDP risk were analyzed using logistic regression, with false discovery rate (FDR) correction applied to calculate adjusted <i>P</i>-values in multivariate analysis. The joint effects of the seven SCFAs were evaluated using weighted quantile sum (WQS) regression.</p><p><strong>Results: </strong>HDP cases exhibited significantly lower median (interquartile range) valerate levels than controls (9 (5-14) <i>vs</i>. 10 (6-18) ng/mL, <i>P</i> = 0.001). Among the seven analyzed SCFAs, isobutyrate and isovalerate demonstrated the highest correlation coefficient at 0.85 (<i>P <</i> 0.001). Each interquartile range increase in valerate content was associated with a low risk of HDP, yielding an adjusted odds ratio (a<i>OR</i>) of 0.699 (95% confidence interval (<i>CI</i>): 0.516-0.946, FDR-corrected <i>P</i> = 0.047). Isobutyrate and hexanoate were also inversely associated with HDP after multivariate adjustment and FDR correction (both <i>P</i> = 0.047), with a<i>OR</i>s of 0.899 (95% <i>CI</i>: 0.826-0.980) and 0.686 (95% <i>CI</i>: 0.508-0.927), respectively. WQS regression revealed that joint SCFA exposure was associated with a decreased risk of HDP (a<i>OR</i>: 0.230, 95% <i>CI</i>: 0.105-0.506) and GH (a<i>OR</i>: 0.740, 95% <i>CI</i>: 0.571-0.933).</p><p><strong>Conclusion: </strong>Plasma levels of valerate, isobutyrate, and hexanoate are inversely associated with HDP risk. Furthermore, the combined effect of these SCFAs is linked to a lower incidence of both HDP and GH. These findings suggest that circulating SCFAs may serve as potential early biomarkers for HDP.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"371-379"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Evaluation of the Guidelines for Premature Rupture of Membranes Based on the Appraisal of Guidelines for Research and Evaluation II, the Scientific, Transparent, and Applicable Rankings, and the Reporting Items for Practice Guidelines in Health Care Methods. 基于《研究与评价指南ⅱ》、《卫生保健方法实践指南》的科学性、透明性和适用性排名及报告项目的《膜早破指南》评价
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-06-23 DOI: 10.1097/FM9.0000000000000368
Ruohan Wang, Mingyue Guo, Weishe Zhang, Qi Li, Yiran Fu, Qi Wang, Biaobiao Wang, Caihong Hu, Jingrui Huang
{"title":"An Evaluation of the Guidelines for Premature Rupture of Membranes Based on the Appraisal of Guidelines for Research and Evaluation II, the Scientific, Transparent, and Applicable Rankings, and the Reporting Items for Practice Guidelines in Health Care Methods.","authors":"Ruohan Wang, Mingyue Guo, Weishe Zhang, Qi Li, Yiran Fu, Qi Wang, Biaobiao Wang, Caihong Hu, Jingrui Huang","doi":"10.1097/FM9.0000000000000368","DOIUrl":"10.1097/FM9.0000000000000368","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"429-431"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnesium Sulfate, Nicardipine, and Volatile Anesthetics in Severe Preeclampsia: Clinical and Mechanistic Implications for Uterine Atony and Postpartum Hemorrhage. 硫酸镁、尼卡地平和挥发性麻醉剂治疗重度子痫前期:子宫张力和产后出血的临床和机制意义。
IF 1.7
Maternal-fetal medicine (Wolters Kluwer Health, Inc.) Pub Date : 2026-10-01 Epub Date: 2026-07-29 DOI: 10.1097/FM9.0000000000000372
Mohammed Said Bouya, Zakariya Hamdani, Najib Bouhabba
{"title":"Magnesium Sulfate, Nicardipine, and Volatile Anesthetics in Severe Preeclampsia: Clinical and Mechanistic Implications for Uterine Atony and Postpartum Hemorrhage.","authors":"Mohammed Said Bouya, Zakariya Hamdani, Najib Bouhabba","doi":"10.1097/FM9.0000000000000372","DOIUrl":"10.1097/FM9.0000000000000372","url":null,"abstract":"<p><p>Severe preeclampsia frequently requires the concurrent administration of magnesium sulfate, intravenous nicardipine, and volatile anesthetics during the peri-delivery period, exposing the myometrium to convergent inhibition of calcium-dependent contraction. We conducted a narrative review guided by the Scale for the Assessment of Narrative Review Articles framework. We searched PubMed/MEDLINE and screened reference lists through March 2026, prioritizing mechanistic studies, human myometrial experiments, clinical cohorts, randomized trials, meta-analyses, and contemporary obstetric anesthesia guidance. The evidence indicates that convergence occurs at multiple levels of the excitation-contraction coupling machinery, including L-type calcium channel influx, inositol 1,4,5-trisphosphate-mediated intracellular calcium release, oxytocin receptor signaling, intercellular coupling through connexin-43 gap junctions, and calcium sensitization via the Ras homolog family member A (RhoA)/Rho-kinase pathway. Magnesium sulfate acts as a broad calcium antagonist, nicardipine blocks L-type calcium channels, and volatile anesthetics depress spontaneous and oxytocin-induced force generation. Clinical evidence is more heterogeneous: magnesium sulfate shows mixed hemorrhagic associations, direct postpartum hemorrhage data for nicardipine remain sparse, and general anesthesia is associated with greater hemorrhagic risk than neuraxial techniques. This \"tocolytic triad\" is therefore best viewed as a mechanistically grounded risk model rather than a validated clinical syndrome. We propose a graded exposure-burden care bundle, anchored in quantified blood loss assessment, to align hemorrhage preparedness with cumulative pharmacologic inhibition of postpartum uterine contraction.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"8 4","pages":"417-425"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书